
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>doi: 10.1016/j.nurt.2010.03.007 , 10.1097/00019052-199906000-00001 , 10.1201/b13388-10 , 10.1201/b16337-5 , 10.1097/00019052-200006000-00006 , 10.1093/med/9780198746690.003.0588 , 10.1201/9780429299476-6 , 10.1093/med/9780199204854.003.2408_update_001 , 10.1097/00019052-200206000-00010 , 10.1093/med/9780199204854.003.2408_update_003 , 10.1097/00019052-200106000-00008 , 10.1093/med/9780199204854.003.2408
pmc: PMC5084094
doi: 10.1016/j.nurt.2010.03.007 , 10.1097/00019052-199906000-00001 , 10.1201/b13388-10 , 10.1201/b16337-5 , 10.1097/00019052-200006000-00006 , 10.1093/med/9780198746690.003.0588 , 10.1201/9780429299476-6 , 10.1093/med/9780199204854.003.2408_update_001 , 10.1097/00019052-200206000-00010 , 10.1093/med/9780199204854.003.2408_update_003 , 10.1097/00019052-200106000-00008 , 10.1093/med/9780199204854.003.2408
pmc: PMC5084094
Abstract Headache is among the most common of human maladies. So much so that it is generally (and often incorrectly) assumed to be understood, especially by doctors. The classification of headache, with formal definitions of different diagnostic entities, by the International Headache Society into (1) primary—occurring in the absence of external causes, and (2) secondary—some of which may have sinister cause, has greatly simplified the description, understanding, and management of this often challenging symptom. It also allows those headaches with serious or life-threatening consequences to be distinguished from other forms. This chapter examines the various types of headache, from primary headaches and migraine, and tension-type to secondary headache and other forms.
OCCIPITAL NERVE-STIMULATION, TRANSCRANIAL MAGNETIC STIMULATION, Clinical Trials as Topic, RECEPTOR, Neuropeptides, Headache, Brain, CONTROLLED TRIAL/, 5-HT1B/1D AGONISTS, Serotonin 5-HT1 Receptor Agonists, DEFINING REFRACTORY MIGRAINE, Serotonin Receptor Agonists, INTRACTABLE CLUSTER HEADACHE, DOUBLE-BLIND, Humans, NITRIC-OXIDE SYNTHASE, Nitric Oxide Synthase, TERM-FOLLOW-UP
OCCIPITAL NERVE-STIMULATION, TRANSCRANIAL MAGNETIC STIMULATION, Clinical Trials as Topic, RECEPTOR, Neuropeptides, Headache, Brain, CONTROLLED TRIAL/, 5-HT1B/1D AGONISTS, Serotonin 5-HT1 Receptor Agonists, DEFINING REFRACTORY MIGRAINE, Serotonin Receptor Agonists, INTRACTABLE CLUSTER HEADACHE, DOUBLE-BLIND, Humans, NITRIC-OXIDE SYNTHASE, Nitric Oxide Synthase, TERM-FOLLOW-UP
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
